References
- Thompson W G. Nonulcer dyspepsia. Can Med Assoc J 1984; 130: 565–569
- Kingham J G, Fairclough P D, Dawson A M. What is indigestion. J R Soc Med 1983; 76: 183–186
- Talley N J, Piper D W. The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol 1985; 20: 896–900
- Nyren O, Adami H O, Gustavsson S, Lindgren P G, Loof L, Nyberg A. The ‘epigastric distress syndrome’: a possible disease entity identified by history and endoscopy in patients with non-ulcer dyspepsia. J Clin Gastroenterol 1987; 9: 303–309
- Talley N J, Philips S F. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med 1988; 108: 865–879
- Dotevall G. Stress and common intestinal disorders. A comprehensive approach. Praeger, New York 1985; 47–60
- Hansesn H. Psedo-ulcus ventriculi mit besonderer berucksichtigung der benignen tuberkulose. Levtg and Munksgaard, Copenhagen 1932; 21: 69
- Bockus H L. Gastroenterology. W.B. Saunders, Philadelphia 1963; Vol. 1: 521
- Alvarez W C. The syndrome of mild reverse peristalsis. JAMA 1917; 69: 2018–2024
- Alvarez W C. Indigestion and pain. Hoeber, New York 1943
- Wingate D L. Functional disorders of the stomach and small bowel. Scand J Gastroenterol 1987; 22: 62–65, suppl 128
- Krag E. Non-ulcer dyspepsia introduction: epidemiological data. Scand J Gastroenterol 1982; 17: 6–8, suppl 79
- Nyren O, Adami H O, Gustavsson S, Loof L. Excess sick listing in social and economic non ulcer dyspepsia. J Clin Gastroenterol 1986; 8: 339–345
- Gershon M D, Erde S M. The nervous system of the gut. Gastroenterology 1981; 80: 1571–1594
- Van Praag H M. Central monoamine metabolism in depressions: serotonin and related compounds. Comp Psychiatry 1980; 21: 30–43
- Gilman A G, Goodman L S, Gilman A. The pharmacological basis of therapeutics. Bailliére Tindall, London 1980
- Warner R P. Hyperserotoninaemia in functional gastrointestinal disease. Ann Intern Med 1963; 59: 464–476
- Harrison R J. Textbook of internal medicine. Hod-der and Staughton, London 1986
- Quattrone A, Tedeschi A, Aguglia V, Scopaccasa F, Direnzo G F, Annunziato L. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxy tryptaminergic neurons: studies with fenfluramine. Br J Pharmacol 1983; 16: 471–475
- Charig E M, Anderson I M, Robinson J M, Nutt D J, Cowen P J. L-Tryptophan and prolactin release: evidence for interaction between 5HT1 and 5HT2 receptors. Hum Psychopharmacol 1987; 1: 93–97
- Cowen P J, Anderson I M. 5HT neuroendocrin-ology. The biology of depression, JFW Deakin. Royal College of Psychiatrists, London 1986; 71–89
- Neuhauser H, Laakmann G, Knossalla A. Neuroendocrine effects of buspirone. 16th CINP Congress. Psychopharmacology 1988; 96: 393, suppl 1
- Yatham L N, Barry S, Dinan T G. Serotonin receptors, buspirone, and premenstrual syndrome. Lancet 1989; 1: 1447–1448
- Marshall B J. Campylobacter pyloris and gastritis. J Infect Dis 1986; 4: 650–657
- Lovgren T, Hemmilon I, Patterson K, Halonen P. Alternative immunoassays- time resolved fluorometry in immunoassays, W P. Collins. John Wiley & Sons Ltd., London 1985